Incyte Officer Pablo Cagnoni Files Form 144 to Sell $2.80M in Common Stock
INCYTE CORP
Subscribe to track INCY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Filing Alert: INCYTE CORP ($INCY)
Insider: Pablo Cagnoni (Officer) Proposed Sale: 23,218 Common shares (~$2.80M) Price / Share: ~$120.49 Acquisition: Stock Option Exercise (Cash payment, 09/15/2026) Broker: Morgan Stanley Smith Barney LLC 10b5-1 Plan Date: 04/30/2026
Note: Officer has sold 48,132 shares (~$5.86M) over the prior 3 months.
Comprehensive Analysis
Executive Summary
On September 15, 2026, Pablo Cagnoni, an Officer at Incyte Corporation ($INCY), filed a Form 144 notice proposing the sale of 23,218 shares of common stock with an aggregate market value of approximately $2,797,571.24 (~$120.49 per share).
Transaction & Acquisition Details
- Securities to be Sold: 23,218 common shares.
- Acquisition Nature: Acquired on September 15, 2026, via a Stock Option Exercise from the issuer, paid in cash.
- Trading Plan: Executed pursuant to a Rule 10b5-1 pre-scheduled trading plan adopted on April 30, 2026.
- Executing Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
Recent Historical Activity (Past 3 Months)
In addition to this planned transaction, the reporting person has executed consistent weekly/bi-weekly sales under the trading plan over the preceding three months:
- 08/19/2026: 10,801 shares sold for $1,356,189.76
- 08/12/2026: 10,803 shares sold for $1,296,773.75
- 08/05/2026: 10,640 shares sold for $1,305,450.33
- 07/31/2026: 15,888 shares sold for $1,901,833.32
Total proceeds realized in the past 90 days (excluding the current proposed sale) amount to ~$5,860,247 across 48,132 shares.
Market Impact & Significance
The filing represents a Medium trading significance. The transaction represents an exercise-and-sell execution under a pre-established Rule 10b5-1 plan adopted earlier in the year. The proposed sale of 23,218 shares represents roughly 0.011% of Incyte's 202,697,746 outstanding shares, presenting minimal direct market dilution.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
